Xilio Therapeutics Inc (XLO)
1.08
-0.04
(-3.57%)
USD |
NASDAQ |
May 16, 16:00
1.06
-0.02
(-1.85%)
Pre-Market: 20:00
Xilio Therapeutics Total Assets (Quarterly): 82.61M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 82.61M |
| December 31, 2023 | 60.93M |
| September 30, 2023 | 77.84M |
| June 30, 2023 | 92.36M |
| March 31, 2023 | 111.50M |
| December 31, 2022 | 139.16M |
| September 30, 2022 | 157.41M |
| Date | Value |
|---|---|
| June 30, 2022 | 178.13M |
| March 31, 2022 | 196.35M |
| December 31, 2021 | 218.06M |
| September 30, 2021 | 120.72M |
| June 30, 2021 | 140.02M |
| December 31, 2020 | 36.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
36.32M
Minimum
Dec 2020
218.06M
Maximum
Dec 2021
123.96M
Average
120.72M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Gilead Sciences Inc | 56.29B |
| FibroGen Inc | 365.87M |
| Avalo Therapeutics Inc | 20.99M |
| IGM Biosciences Inc | 376.13M |
| AEON Biopharma Inc | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 56.84M |
| Shareholders Equity (Quarterly) | 25.76M |